Kerala Ayurveda, a company in the Pharmaceuticals industry, reported revenue of ₹36 crore and a net loss of ₹6.10 crore for the September 2026 quarter.
Kerala Ayurveda (BSE: KERALAYUR) closed at ₹136.45 on 20 Nov 2026, down 64.4% over the past year. Its market capitalisation is ₹186 crore.
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.